RT Journal Article
T1 Role of radiotherapy in the treatment of metastatic head and neck cancer.
A1 Ordoñez, Rafael
A1 Otero, Ana
A1 Jerez, Inmaculada
A1 Medina, Jose A
A1 Lupiañez-Pérez, Yolanda
A1 Gomez-Millan, Jaime
K1 head and neck cancer
K1 oligometastatic disease
K1 palliative
K1 radiotherapy
AB In metastatic or locally advanced head and neck tumors that present in frail patients or after chemotherapy progression, radiotherapy is normally used as a palliative treatment, with a high rate of symptom palliation and improvement in quality of life. However, there is controversy about what the optimal regimen is. Moreover, despite the poor prognosis of metastatic head and neck cancer, different retrospective studies have shown that a minority of patients with oligometastatic disease experience prolonged disease-free survival after adding curative radiotherapy treatment to the metastatic disease and/or primary tumor. Different retrospective studies have identified clinical prognostic factors that may be used to select candidate patients with metastatic head and neck cancer for a radical approach with radiotherapy. The purpose of this manuscript is to review the role of radiotherapy in metastatic and locally advanced head and neck tumors.
SN 1178-6930
YR 2019
FD 2019-01-18
LK http://hdl.handle.net/10668/13491
UL http://hdl.handle.net/10668/13491
LA en
DS RISalud
RD Apr 4, 2025